(NASDAQ: AMED) AMEDISYS's forecast annual revenue growth rate of 8.83% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 8.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.17%.
AMEDISYS's revenue in 2022 is $2,222,225,000.On average, 8 Wall Street analysts forecast AMED's revenue for 2022 to be $76,436,747,470, with the lowest AMED revenue forecast at $75,944,507,015, and the highest AMED revenue forecast at $76,871,855,200. On average, 8 Wall Street analysts forecast AMED's revenue for 2023 to be $84,176,994,114, with the lowest AMED revenue forecast at $82,144,091,845, and the highest AMED revenue forecast at $86,047,618,594.
In 2024, AMED is forecast to generate $93,844,151,071 in revenue, with the lowest revenue forecast at $91,984,015,039 and the highest revenue forecast at $95,539,338,342.